• COMMENT

Hopes, fears and uncertainty: life scientists react to Trump’s election victory

Leading biomedical researchers outline their priorities for the incoming administration.
By
  1. Amander Clark

    1. Amander Clark is the director of the University of California, Los Angeles, Center for Reproductive Science, Health and Education.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  2. Eric Topol

    1. Eric Topol is a professor and executive vice-president of the Scripps Research Translational Institute, La Jolla, California.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  3. Hank Greely

    1. Hank Greely is a professor of law and director of the Center for Law and the Biosciences, Stanford University, California.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  4. Salim S. Abdool Karim

    1. Salim S. Abdool Karim is a director of the Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa, and a professor in the Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  5. Quarraisha Abdool Karim

    1. Quarraisha Abdool Karim is a director of the Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa, and a professor in the Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City

    View author publications

    You can also search for this author in PubMed  Google Scholar

  6. Ramanan Laxminarayan

    1. Ramanan Laxminarayan is president of the One Health Trust in Washington DC, and a senior research scholar at Princeton University, Princeton, New Jersey.

    View author publications

    You can also search for this author in PubMed  Google Scholar

Access through your institution
Buy or subscribe

The re-election of Donald Trump as US president raises the prospect of big changes in US science, in terms of policy, funding and research. Nature asked six life scientists which priorities they’d like to see the administration focus on once Trump takes office in January next year.

Access options

Access through your institution

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 635, 812-814 (2024)

doi: https://doi.org/10.1038/d41586-024-03813-4

Competing Interests

A.C. is past president of the International Society for Stem Cell Research. S.S.A.K. is a special adviser on pandemics to the World Health Organization director-general and is the chair of the Emergency Consultative Group that advises the Africa Centres for Disease Control and Prevention’s director-general on continental epidemics. Q.A.K. is co-chair of the US President’s Emergency Plan for AIDS Relief (PEPFAR) Scientific Advisory Committee and is a board member of the US Friends of the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM).

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing